| Year |
Citation |
Score |
| 2021 |
Rogic A, Pant I, Grumolato L, Fernandez-Rodriguez R, Edwards A, Das S, Sun A, Yao S, Qiao R, Jaffer S, Sachidanandam R, Akturk G, Karlic R, Skobe M, Aaronson SA. High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer. Nature Communications. 12: 6889. PMID 34824220 DOI: 10.1038/s41467-021-27108-8 |
0.302 |
|
| 2020 |
Coste A, Karagiannis GS, Wang Y, Xue EA, Lin Y, Skobe M, Jones JG, Oktay MH, Condeelis JS, Entenberg D. Hematogenous Dissemination of Breast Cancer Cells From Lymph Nodes Is Mediated by Tumor MicroEnvironment of Metastasis Doorways. Frontiers in Oncology. 10: 571100. PMID 33194666 DOI: 10.3389/fonc.2020.571100 |
0.425 |
|
| 2019 |
Edwards AK, Skobe M, Rogic A, Bosenberg M. Abstract B156: Characterization and role of CCR8+ regulatory T-cells in mouse models of malignant melanoma Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B156 |
0.482 |
|
| 2018 |
Rogic A, Auger F, Skobe M. Isolation of Human Skin Lymphatic Endothelial Cells and 3D Reconstruction of the Lymphatic Vasculature In Vitro. Methods in Molecular Biology (Clifton, N.J.). 1846: 279-290. PMID 30242766 DOI: 10.1007/978-1-4939-8712-2_18 |
0.572 |
|
| 2017 |
Gibot L, Galbraith T, Bourland J, Rogic A, Skobe M, Auger FA. Tissue-engineered 3D human lymphatic microvascular network for in vitro studies of lymphangiogenesis. Nature Protocols. 12: 1077-1088. PMID 28448484 DOI: 10.1038/Nprot.2017.025 |
0.393 |
|
| 2017 |
Berisa M, Podgrabinska S, Chipuk J, Skobe M. Abstract LB-333: Lymphatic endothelium increases antioxidant capacity of triple-negative breast cancer cells and protects from cell death Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-333 |
0.419 |
|
| 2017 |
Barrette AM, Lenoir B, Skobe M, Birtwistle MR. Abstract 4527: Estimating tumor cell dissemination rates through lymph and blood via computational modeling Cancer Research. 77: 4527-4527. DOI: 10.1158/1538-7445.Am2017-4527 |
0.381 |
|
| 2016 |
Gibot L, Galbraith T, Kloos B, Das S, Lacroix DA, Auger FA, Skobe M. Cell-based approach for 3D reconstruction of lymphatic capillaries in vitro reveals distinct functions of HGF and VEGF-C in lymphangiogenesis. Biomaterials. 78: 129-39. PMID 26694987 DOI: 10.1016/J.Biomaterials.2015.11.027 |
0.674 |
|
| 2015 |
Griswold RE, Podgrabinska S, Das S, Griffith B, Peskin CS, Skobe M. Abstract 1931: Mathematical modeling predicts exponential growth kinetics for metastases in the lymphatic vessels in the absence of vascularization Cancer Research. 75: 1931-1931. DOI: 10.1158/1538-7445.Am2015-1931 |
0.465 |
|
| 2014 |
Podgrabinska S, Skobe M. Role of lymphatic vasculature in regional and distant metastases. Microvascular Research. 95: 46-52. PMID 25026412 DOI: 10.1016/J.Mvr.2014.07.004 |
0.525 |
|
| 2014 |
Serasinghe MN, Missert DJ, Asciolla JJ, Podgrabinska S, Wieder SY, Izadmehr S, Belbin G, Skobe M, Chipuk JE. Anti-apoptotic BCL-2 proteins govern cellular outcome following B-RAFV600E inhibition and can be targeted to reduce resistance Oncogene. DOI: 10.1038/Onc.2014.21 |
0.305 |
|
| 2013 |
Das S, Sarrou E, Podgrabinska S, Cassella M, Mungamuri SK, Feirt N, Gordon R, Nagi CS, Wang Y, Entenberg D, Condeelis J, Skobe M. Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. The Journal of Experimental Medicine. 210: 1509-28. PMID 23878309 DOI: 10.1084/Jem.20111627 |
0.494 |
|
| 2012 |
Skobe M. Lymphatic vessels and cancer. Lymphatic Research and Biology. 10: 96. PMID 22984904 DOI: 10.1089/Lrb.2012.1032 |
0.345 |
|
| 2012 |
Das S, Sarrou E, Cassella M, Feirt N, Skobe M. Abstract 4368: Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses Cancer Research. 72: 4368-4368. DOI: 10.1158/1538-7445.Am2012-4368 |
0.485 |
|
| 2010 |
Das S, Ladell DS, Podgrabinska S, Ponomarev V, Nagi C, Fallon JT, Skobe M. Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases. Cancer Research. 70: 1814-24. PMID 20179201 DOI: 10.1158/0008-5472.Can-09-3675 |
0.555 |
|
| 2010 |
Lederle W, Linde N, Heusel J, Bzyl J, Woenne EC, Zwick S, Skobe M, Kiessling F, Fusenig NE, Mueller MM. Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas American Journal of Pathology. 176: 981-994. PMID 20042679 DOI: 10.2353/Ajpath.2010.080998 |
0.552 |
|
| 2009 |
Skobe M, Dana R. Blocking the path of lymphatic vessels. Nature Medicine. 15: 993-4. PMID 19734869 DOI: 10.1038/Nm0909-993 |
0.406 |
|
| 2009 |
Podgrabinska S, Kamalu O, Mayer L, Shimaoka M, Snoeck H, Randolph GJ, Skobe M. Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 183: 1767-79. PMID 19587009 DOI: 10.4049/Jimmunol.0802167 |
0.388 |
|
| 2008 |
Das S, Skobe M. Lymphatic vessel activation in cancer. Annals of the New York Academy of Sciences. 1131: 235-41. PMID 18519976 DOI: 10.1196/Annals.1413.021 |
0.519 |
|
| 2007 |
Shawber CJ, Funahashi Y, Francisco E, Vorontchikhina M, Kitamura Y, Stowell SA, Borisenko V, Feirt N, Podgrabinska S, Shiraishi K, Chawengsaksophak K, Rossant J, Accili D, Skobe M, Kitajewski J. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. The Journal of Clinical Investigation. 117: 3369-82. PMID 17948123 DOI: 10.1172/Jci24311 |
0.592 |
|
| 2007 |
Furtado GC, Marinkovic T, Martin AP, Garin A, Hoch B, Hubner W, Chen BK, Genden E, Skobe M, Lira SA. Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid. Proceedings of the National Academy of Sciences of the United States of America. 104: 5026-31. PMID 17360402 DOI: 10.1073/Pnas.0606697104 |
0.341 |
|
| 2007 |
Skobe M, Godbold JH. Anti-VEGFR-3 Therapy and Lymph Node Metastasis Cancer Research. 67: 5056-5056. DOI: 10.1158/0008-5472.Can-07-0620 |
0.59 |
|
| 2006 |
Lederle W, Stark HJ, Skobe M, Fusenig NE, Mueller MM. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. The American Journal of Pathology. 169: 1767-83. PMID 17071599 DOI: 10.2353/Ajpath.2006.060120 |
0.532 |
|
| 2006 |
Grossmann C, Podgrabinska S, Skobe M, Ganem D. Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. Journal of Virology. 80: 7179-85. PMID 16809323 DOI: 10.1128/Jvi.01603-05 |
0.426 |
|
| 2006 |
Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, Pytowski B, Skobe M. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Research. 66: 2650-7. PMID 16510584 DOI: 10.1158/0008-5472.Can-05-1843 |
0.668 |
|
| 2006 |
Angeli V, Ginhoux F, Llodrà J, Quemeneur L, Frenette PS, Skobe M, Jessberger R, Merad M, Randolph GJ. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity. 24: 203-15. PMID 16473832 DOI: 10.1016/J.Immuni.2006.01.003 |
0.387 |
|
| 2006 |
Angeli V, Ginhoux F, Llodrà J, Quemeneur L, Frenette PS, Skobe M, Jessberger R, Merad M, Randolph GJ. B Cell-Driven Lymphangiogenesis in Inflamed Lymph Nodes Enhances Dendritic Cell Mobilization Immunity. 25: 689. DOI: 10.1016/J.Immuni.2006.10.002 |
0.389 |
|
| 2005 |
Goldman J, Le TX, Skobe M, Swartz MA. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin. Circulation Research. 96: 1193-9. PMID 15890974 DOI: 10.1161/01.Res.0000168918.27576.78 |
0.572 |
|
| 2005 |
Pytowski B, Goldman J, Persaud K, Wu Y, Witte L, Hicklin DJ, Skobe M, Boardman KC, Swartz MA. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. Journal of the National Cancer Institute. 97: 14-21. PMID 15632376 DOI: 10.1093/Jnci/Dji003 |
0.567 |
|
| 2005 |
Sugaya M, Watanabe T, Yang A, Starost MF, Kobayashi H, Atkins AM, Borris DL, Hanan EA, Schimel D, Bryant MA, Roberts N, Skobe M, Staskus KA, Kaldis P, Blauvelt A. Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter. Blood. 105: 2356-63. PMID 15536152 DOI: 10.1182/Blood-2004-08-3364 |
0.474 |
|
| 2003 |
Pepper MS, Skobe M. Lymphatic endothelium: morphological, molecular and functional properties. The Journal of Cell Biology. 163: 209-13. PMID 14581448 DOI: 10.1083/Jcb.200308082 |
0.453 |
|
| 2003 |
Pepper MS, Tille JC, Nisato R, Skobe M. Lymphangiogenesis and tumor metastasis. Cell and Tissue Research. 314: 167-77. PMID 12883995 DOI: 10.1007/S00441-003-0748-7 |
0.613 |
|
| 2003 |
Gruss CJ, Satyamoorthy K, Berking C, Lininger J, Nesbit M, Schaider H, Liu ZJ, Oka M, Hsu MY, Shirakawa T, Li G, Bogenrieder T, Carmeliet P, El-Deiry WS, Eck SL, ... ... Skobe M, et al. Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice. The Journal of Investigative Dermatology. 120: 683-92. PMID 12648235 DOI: 10.1046/J.1523-1747.2003.12112.X |
0.442 |
|
| 2003 |
Rafii S, Skobe M. Splitting vessels: keeping lymph apart from blood. Nature Medicine. 9: 166-8. PMID 12563334 DOI: 10.1038/Nm0203-166 |
0.474 |
|
| 2002 |
Cassella M, Skobe M. Lymphatic vessel activation in cancer. Annals of the New York Academy of Sciences. 979: 120-30. PMID 12543722 |
0.483 |
|
| 2002 |
Podgrabinska S, Braun P, Velasco P, Kloos B, Pepper MS, Skobe M. Molecular characterization of lymphatic endothelial cells. Proceedings of the National Academy of Sciences of the United States of America. 99: 16069-74. PMID 12446836 DOI: 10.1073/Pnas.242401399 |
0.672 |
|
| 2002 |
Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW, Quertermous T, Alitalo K, Rockson SG. Therapeutic lymphangiogenesis with human recombinant VEGF-C. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 1985-7. PMID 12397087 DOI: 10.1096/Fj.02-0401Fje |
0.532 |
|
| 2002 |
Hawighorst T, Skobe M, Streit M, Hong YK, Velasco P, Brown LF, Riccardi L, Lange-Asschenfeldt B, Detmar M. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth. The American Journal of Pathology. 160: 1381-92. PMID 11943723 DOI: 10.1016/S0002-9440(10)62565-5 |
0.553 |
|
| 2001 |
Swartz MA, Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Microscopy Research and Technique. 55: 92-9. PMID 11596154 DOI: 10.1002/Jemt.1160 |
0.519 |
|
| 2001 |
Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. The American Journal of Pathology. 159: 893-903. PMID 11549582 DOI: 10.1016/S0002-9440(10)61765-8 |
0.606 |
|
| 2001 |
Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Medicine. 7: 192-8. PMID 11175850 DOI: 10.1038/84643 |
0.557 |
|
| 2000 |
Skobe M, Detmar M. Structure, Function, and Molecular Control of the Skin Lymphatic System Journal of Investigative Dermatology Symposium Proceedings. 5: 14-19. PMID 11147669 DOI: 10.1046/J.1087-0024.2000.00001.X |
0.548 |
|
| 2000 |
Detmar M, Velasco P, Richard L, Claffey KP, Streit M, Riccardi L, Skobe M, Brown LF. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. The American Journal of Pathology. 156: 159-67. PMID 10623663 DOI: 10.1016/S0002-9440(10)64715-3 |
0.592 |
|
| 1999 |
Skobe M, Brown LF, Tognazzi K, Ganju RK, Dezube BJ, Alitalo K, Detmar M. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. The Journal of Investigative Dermatology. 113: 1047-53. PMID 10594750 DOI: 10.1046/J.1523-1747.1999.00798.X |
0.601 |
|
| 1999 |
Streit M, Velasco P, Brown LF, Skobe M, Richard L, Riccardi L, Lawler J, Detmar M. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. The American Journal of Pathology. 155: 441-52. PMID 10433937 DOI: 10.1016/S0002-9440(10)65140-1 |
0.454 |
|
| 1998 |
Bajou K, Noël A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D, Foidart JM. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization Nature Medicine. 4: 923-928. PMID 9701244 DOI: 10.1038/Nm0898-923 |
0.457 |
|
| 1998 |
Skobe M, Fusenig NE. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proceedings of the National Academy of Sciences of the United States of America. 95: 1050-1055. PMID 9448283 DOI: 10.1073/Pnas.95.3.1050 |
0.469 |
|
| 1997 |
Skobe M, Rockwell P, Goldstein N, Vosseler S, Fusenig NE. Halting angiogenesis suppresses carcinoma cell invasion Nature Medicine. 3: 1222-1227. PMID 9359696 DOI: 10.1016/S0022-5347(05)68639-9 |
0.568 |
|
| Show low-probability matches. |